David Béchard

1.4k total citations
17 papers, 1.1k citations indexed

About

David Béchard is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, David Béchard has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 7 papers in Oncology and 3 papers in Surgery. Recurrent topics in David Béchard's work include Inflammation biomarkers and pathways (6 papers), CAR-T cell therapy research (5 papers) and Immune Cell Function and Interaction (5 papers). David Béchard is often cited by papers focused on Inflammation biomarkers and pathways (6 papers), CAR-T cell therapy research (5 papers) and Immune Cell Function and Interaction (5 papers). David Béchard collaborates with scholars based in France, United States and United Kingdom. David Béchard's co-authors include Philippe Lassalle, Arnaud Scherpereel, André‐Bernard Tonnel, Thibaut Gentina, Anne Janin, Maryse Delehedde, Malcolm Lyon, Marc Aumercier, Anne Tsicopoulos and Sandrine Sarrazin and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

David Béchard

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Béchard France 11 881 423 174 170 148 17 1.1k
Xiaolun Huang China 18 672 0.8× 771 1.8× 122 0.7× 152 0.9× 351 2.4× 52 1.7k
Sachiko Matsuzaki France 30 1.1k 1.2× 297 0.7× 49 0.3× 93 0.5× 231 1.6× 77 2.6k
E Larsson Sweden 15 339 0.4× 215 0.5× 42 0.2× 134 0.8× 139 0.9× 45 1000
Roberto Bullani Switzerland 10 307 0.3× 84 0.2× 586 3.4× 229 1.3× 317 2.1× 14 1.3k
Ronan Mullan Ireland 20 480 0.5× 127 0.3× 38 0.2× 213 1.3× 401 2.7× 43 1.2k
Carlo Socci Italy 16 480 0.5× 464 1.1× 17 0.1× 77 0.5× 156 1.1× 38 1.2k
Nozomi Koyamada Japan 15 203 0.2× 802 1.9× 38 0.2× 74 0.4× 182 1.2× 35 1.1k
Fred H. Hsieh United States 15 496 0.6× 112 0.3× 131 0.8× 48 0.3× 147 1.0× 41 1.4k
Jacqueline Quach United States 7 327 0.4× 101 0.2× 159 0.9× 250 1.5× 405 2.7× 8 1.1k
Alessandra Petrelli Italy 19 376 0.4× 280 0.7× 34 0.2× 110 0.6× 186 1.3× 39 901

Countries citing papers authored by David Béchard

Since Specialization
Citations

This map shows the geographic impact of David Béchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Béchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Béchard more than expected).

Fields of papers citing papers by David Béchard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Béchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Béchard. The network helps show where David Béchard may publish in the future.

Co-authorship network of co-authors of David Béchard

This figure shows the co-authorship network connecting the top 25 collaborators of David Béchard. A scholar is included among the top collaborators of David Béchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Béchard. David Béchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tomala, Jakub, Milada Šírová, Guy de Martynoff, et al.. (2022). SOT101 induces NK cell cytotoxicity and potentiates antibody-dependent cell cytotoxicity and anti-tumor activity. Frontiers in Immunology. 13. 989895–989895. 8 indexed citations
2.
3.
Garralda, Elena, Stéphane Champiat, Patricia LoRusso, et al.. (2021). 484 Preliminary efficacy of the IL-15 superagonist SO-C101 in combination with pembrolizumab in patients with advanced/metastatic solid tumors. SHILAP Revista de lepidopterología. A514–A514. 2 indexed citations
4.
Desbois, Mélanie, Mélinda Charrier, Benjamin Besse, et al.. (2020). IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment. Journal for ImmunoTherapy of Cancer. 8(1). e000632–e000632. 34 indexed citations
5.
6.
Adkins, Irena, et al.. (2020). 563 Pharmacodynamics and pharmacokinetics of SO-C101 in cynomolgus monkeys. SHILAP Revista de lepidopterología. A339.2–A339. 1 indexed citations
7.
Desbois, Mélanie, Clélia Coutzac, Elie Marcheteau, et al.. (2016). IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists. The Journal of Immunology. 197(1). 168–178. 51 indexed citations
8.
Teppaz, Géraldine, Laurie Lajoie, Véronique Solé-Jamault, et al.. (2014). Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouse. mAbs. 6(4). 1026–1037. 32 indexed citations
9.
Sarrazin, Sandrine, Estelle Adam, Malcolm Lyon, et al.. (2005). Endocan or endothelial cell specific molecule-1 (ESM-1): A potential novel endothelial cell marker and a new target for cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1765(1). 25–37. 279 indexed citations
10.
Delehedde, Maryse, Hugues Lortat‐Jacob, John T. Gallagher, et al.. (2005). Proteoglycan Involvement in Inflammatory Diseases. New Developments in GAG-Based Therapies. 2(4). 345–357. 2 indexed citations
11.
Sarrazin, Stéphane, David Béchard, Philippe Lassalle, et al.. (2004). Purification and characterization of endocan (endothelial cell‐specific molecule‐1), a circulating proteoglycan involved in tumour progression and inflammatory diseases. International Journal of Experimental Pathology. 85(4). 1 indexed citations
12.
Scherpereel, Arnaud, Thibaut Gentina, Bogdan Grigoriu, et al.. (2003). Overexpression of endocan induces tumor formation.. PubMed. 63(18). 6084–9. 118 indexed citations
13.
Béchard, David, Arnaud Scherpereel, Hamida Hammad, et al.. (2001). Human Endothelial-Cell Specific Molecule-1 Binds Directly to the Integrin CD11a/CD18 (LFA-1) and Blocks Binding to Intercellular Adhesion Molecule-1. The Journal of Immunology. 167(6). 3099–3106. 210 indexed citations
14.
Béchard, David, Thibaut Gentina, Maryse Delehedde, et al.. (2001). Endocan Is a Novel Chondroitin Sulfate/Dermatan Sulfate Proteoglycan That Promotes Hepatocyte Growth Factor/Scatter Factor Mitogenic Activity. Journal of Biological Chemistry. 276(51). 48341–48349. 196 indexed citations
15.
Béchard, David, Véronique Meignin, Arnaud Scherpereel, et al.. (2000). Characterization of the Secreted Form of Endothelial-Cell-Specific Molecule 1 by Specific Monoclonal Antibodies. Journal of Vascular Research. 37(5). 417–425. 159 indexed citations
16.
Bodart, Jean‐François, et al.. (1999). Activation of Xenopus Eggs by the Kinase Inhibitor 6-DMAP Suggests a Differential Regulation of Cyclin B and p39mos Proteolysis. Experimental Cell Research. 253(2). 413–421. 18 indexed citations
17.
Bodart, Jean‐François, et al.. (1999). Inhibition of protein tyrosine phosphatases blocks calcium‐induced activation of metaphase II‐arrested oocytes of Xenopus laevis. FEBS Letters. 457(2). 175–178. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaolun Huang Breakdown of academic impact, for papers by Sachiko Matsuzaki Breakdown of academic impact, for papers by E Larsson Breakdown of academic impact, for papers by Roberto Bullani Breakdown of academic impact, for papers by Ronan Mullan Breakdown of academic impact, for papers by Carlo Socci Breakdown of academic impact, for papers by Nozomi Koyamada Breakdown of academic impact, for papers by Fred H. Hsieh Breakdown of academic impact, for papers by Jacqueline Quach Breakdown of academic impact, for papers by Alessandra Petrelli
Rankless by CCL
2026